Merck Tbk PT

Merck Tbk PT EV/FCF

The EV/FCF (Enterprise Value to Free Cash Flow) of Merck Tbk PT (MERK.JK) as of Oct 19, 2026 is 2.79. In the previous year, EV/FCF (Enterprise Value to Free Cash Flow) was 35.14 — a change of -92.07% (lower).

EV/FCF

2.79

YoY

-92.07%

Last updated:

EV/FCF (Enterprise Value to Free Cash Flow) of Merck Tbk PT is 2025 2.79 . EV/FCF (Enterprise Value to Free Cash Flow) of Merck Tbk PT was 2024 35.14 . It decreases by -92.07% lower compared to the previous year.

The Merck Tbk PT EV/FCF history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EV/FCF
Date
EV/FCF
Jan 1, 2018
7.12 IDR
Jan 1, 2019
-5.29 IDR
Jan 1, 2020
32.57 IDR
Jan 1, 2021
9.92 IDR
Jan 1, 2022
14.19 IDR
Jan 1, 2023
6.80 IDR
Jan 1, 2024
35.14 IDR
Jan 1, 2025
2.79 IDR
The Merck Tbk PT EV/FCF history
YEAREV/FCFYoY
2.79-92.07%
35.14+417.02%
6.80-52.12%
14.19+43.03%
9.92-69.53%
32.57-715.72%
-5.29-174.28%
7.12-66.72%
21.39-70.30%
72.04+465.90%
12.73+126.66%
5.62—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Merck Tbk PT Stock analysis

What does Merck Tbk PT do? Merck Tbk PT is a pharmaceutical company based in Jakarta Timur, DKI Jakarta, operating within the Health Care sector. The company, listed on the Indonesian stock exchange with ticker MERK.JK and ISIN ID1000136609, has been publicly traded since its IPO on July 23, 1981. It employs 376 full-time staff and focuses on the development and distribution of pharmaceutical and chemical products. The company operates through three business segments: Biopharma, which covers ethical pharmaceutical products; Consumer Health, which includes over-the-counter products; and Others, which encompasses additional business activities. Merck Tbk PT is committed to providing personalized treatments for serious diseases and supports initiatives related to reproductive health, including enabling individuals to achieve their goal of becoming parents. The company's official website is https://www.merckgroup.com/id-id, where further information about its operations and services can be accessed. As a publicly listed entity, Merck Tbk PT is subject to regulatory disclosures and financial reporting requirements in Indonesia. The company's primary focus remains on delivering healthcare solutions through its pharmaceutical and chemical offerings, targeting both professional medical markets and consumer health needs. Merck Tbk PT is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Merck Tbk PT stock

EV/FCF (Enterprise Value to Free Cash Flow) of Merck Tbk PT is 2.79 in 2025.

EV/FCF (Enterprise Value to Free Cash Flow) of Merck Tbk PT changed from 35.14 to 2.79, representing a -92.07% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of EV/FCF (Enterprise Value to Free Cash Flow) Merck Tbk PT since 2006 – with annual values, charts, and detailed analysis.

The EV/FCF ratio measures the enterprise value relative to free cash flow. It captures the true cash-generating ability of a business.

To evaluate EV/FCF (Enterprise Value to Free Cash Flow)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for EV/FCF (Enterprise Value to Free Cash Flow).

A 'good' varies by industry and company stage. On Eulerpool, you can compare EV/FCF (Enterprise Value to Free Cash Flow)'s Merck Tbk PT with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Valuation — Merck Tbk PT

All Key Metrics — Merck Tbk PT